As of January 2025 Neurocrine Biosciences has a market cap of €14.16 Billion. This makes Neurocrine Biosciences the world's 1237th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2025 the market cap of Neurocrine Biosciences was reported to be: